BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines weighted-average basic ordinary shares outstanding (M) (M)
Form 10-Q / 10-K (DB)
Latest, Q2 2026
1,451
Period ended Jun 30, 2026
Change on a year earlier
+3.0%
1,408 in Q2 2025
History
35 quarters
Since Q1 2015
Sources
32
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Weighted-average basic ordinary shares outstanding (M) (M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 1,451 | +3.0% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 1,443 | +3.8% | Form 10-Q (filed 2026-05-06) ↗ |
| Q3 2025 | Sep 30, 2025 | 1,433 | +4.1% | Form 10-Q (filed 2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 1,408 | +3.5% | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | 1,390 | +2.6% | Form 10-Q (filed 2025-05-07) ↗ |
| Q3 2024 | Sep 30, 2024 | 1,377 | +1.2% | Form 10-Q (filed 2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | 1,361 | +0.1% | Form 10-Q (filed 2024-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | 1,356 | +0.1% | Form 10-Q (filed 2024-05-08) ↗ |
| Q3 2023 | Sep 30, 2023 | 1,361 | +1.1% | Form 10-Q (filed 2023-11-09) ↗ |
| Q2 2023 | Jun 30, 2023 | 1,360 | +1.8% | Form 10-Q (filed 2023-08-02) ↗ |
| Q1 2023 | Mar 31, 2023 | 1,354 | +1.7% | Form 10-Q (filed 2023-05-04) ↗ |
| Q3 2022 | Sep 30, 2022 | 1,345 | +11.6% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2022 | Jun 30, 2022 | 1,337 | +11.9% | Form 10-Q (filed 2022-08-08) ↗ |
| Q1 2022 | Mar 31, 2022 | 1,332 | +12.0% | Form 10-Q (filed 2022-05-09) ↗ |
| Q3 2021 | Sep 30, 2021 | 1,206 | +5.0% | Form 10-Q (filed 2021-11-04) ↗ |
| Q2 2021 | Jun 30, 2021 | 1,194 | +18.2% | Form 10-Q (filed 2021-08-05) ↗ |
| Q1 2021 | Mar 31, 2021 | 1,189 | +18.3% | Form 10-Q (filed 2021-05-06) ↗ |
| Q3 2020 | Sep 30, 2020 | 1,149 | +47.0% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | 1,010 | +29.9% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2020 | Mar 31, 2020 | 1,005 | +29.7% | Form 10-Q (filed 2020-05-11) ↗ |
| Q3 2019 | Sep 30, 2019 | 782 | +5.6% | Form 10-Q (filed 2019-11-12) ↗ |
| Q2 2019 | Jun 30, 2019 | 778 | +11.3% | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2019 | Mar 31, 2019 | 775 | +15.6% | Form 10-Q (filed 2019-05-09) ↗ |
| Q3 2018 | Sep 30, 2018 | 740 | +35.1% | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2018 | Jun 30, 2018 | 699 | +34.9% | Form 10-Q (filed 2018-08-09) ↗ |
| Q1 2018 | Mar 31, 2018 | 671 | +29.8% | Form 10-Q (filed 2018-05-09) ↗ |
| Q3 2017 | Sep 30, 2017 | 548 | +27.9% | Form 10-Q (filed 2017-11-13) ↗ |
| Q2 2017 | Jun 30, 2017 | 518 | +21.0% | Form 10-Q (filed 2017-08-09) ↗ |
| Q1 2017 | Mar 31, 2017 | 516 | +75.6% | Form 10-Q (filed 2017-05-10) ↗ |
| Q3 2016 | Sep 30, 2016 | 428 | +292.4% | Form 10-Q (filed 2016-11-10) ↗ |
| Q2 2016 | Jun 30, 2016 | 428 | +294.2% | Form 10-Q (filed 2016-08-10) ↗ |
| Q1 2016 | Mar 31, 2016 | 294 | +171.0% | Form 10-Q (filed 2016-05-12) ↗ |
| Q3 2015 | Sep 30, 2015 | 109 | – | Form 10-Q (filed 2016-11-10) ↗ |
| Q2 2015 | Jun 30, 2015 | 109 | – | Form 10-Q (filed 2016-08-10) ↗ |
| Q1 2015 | Mar 31, 2015 | 109 | – | Form 10-Q (filed 2016-05-12) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Weighted-average basic ordinary shares outstanding (M) (M), quarterly Q1 2015–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/fs_sh_basic
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.